ZADITOR

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company:

Approval Status:

Approved July 1999

Specific Treatments:

Ophthalmology

Therapeutic Areas

General Information

ZADITOR (ketotifen fumarate ophthalmic solution) 0.025%, Rx, has been approved for the prevention of itching of the eye due to allergic conjunctivitis.